TLDR
- Injective introduces perpetual futures for pre-IPO companies like OpenAI and SpaceX.
- Over $1 billion traded in real-world asset futures on Injective in just 30 days.
- Injective partners with Republic to democratize retail access to private equity.
- New pre-IPO companies like Monzo, Revolut, and xAI added to Injective’s platform.
Injective has launched a new on-chain financial product that provides retail investors access to pre-IPO companies like OpenAI, SpaceX, and Anthropic through perpetual futures contracts. This groundbreaking move aims to democratize investment opportunities in private equity, offering the public a way to trade exposure to some of the world’s most valuable private companies. The introduction of these perpetual futures marks a significant shift in how private equity markets can be accessed.
New Market for Pre-IPO Companies
Injective has introduced the world’s first perpetual futures markets for private equity, enabling investors to gain exposure to high-profile companies before they go public. This development is seen as a major step in making private equity more accessible.
Unlike traditional futures contracts that have set expiry dates, perpetual futures have no expiration, allowing traders to maintain positions indefinitely.
By launching these on-chain perpetual futures, Injective allows users to invest in companies like OpenAI, SpaceX, and Anthropic, even before they list publicly. The company’s platform facilitates buying futures contracts that reflect the estimated value of these companies, offering a new way for investors to speculate on the success of firms in their early stages.
Partnership with Republic to Expand Access
In August 2025, Injective entered a partnership with Republic, a platform known for democratizing access to private equity markets. Together, they aim to broaden the scope of investment opportunities, particularly for retail investors.
Republic, which plans to tokenize shares of companies like OpenAI and SpaceX, has been working to bridge the gap between traditional private markets and blockchain-based investment systems.
Republic’s involvement has enabled Injective to bring these pre-IPO exposure tools to a broader audience. This collaboration builds on Republic’s earlier announcements to introduce blockchain-based financial instruments known as “Mirror Tokens,” which track shares in private companies. The combined efforts of Injective and Republic signal a shift towards more inclusive access to high-growth sectors, such as artificial intelligence and space exploration.
Surge in Trading Volume
Injective reported a surge in trading activity since the launch of its perpetual futures products. In just a 30-day period, over $1 billion in real-world asset (RWA) perpetual futures contracts were traded on the platform.
This increase in trading volume underscores the growing demand for these new financial products. Investors are keen to take advantage of opportunities in companies that are on the cusp of major breakthroughs, particularly in the tech and AI sectors.
Injective’s blockchain is designed to support these complex financial products, and its success in facilitating this level of trading signals a growing interest in on-chain private equity. With a robust and secure platform, Injective is positioning itself as a key player in the evolving landscape of blockchain-based financial markets.
Expansion Plans and Future Additions
Looking ahead, Injective plans to expand its offering to include additional high-profile private companies. In October 2025, companies such as Monzo, xAI, Revolut, Airtable, and Notion will be added to the platform. These companies represent some of the most valuable startups in the rapidly growing sectors of data and AI, which saw over $100 billion in investments in 2024 alone.
Injective’s expansion into new companies further solidifies its position as a pioneer in the space. The ongoing partnership with Republic and the growing interest from institutional backers such as Binance, Jump Crypto, Pantera, and Mark Cuban also indicate the broader potential for the platform to reshape how investors gain exposure to private equity.
